Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes
Protease-activated receptor-2 (PAR-2) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (−/−) cel...
Gespeichert in:
Veröffentlicht in: | Archives of biochemistry and biophysics 2001-02, Vol.386 (2), p.195-204 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 204 |
---|---|
container_issue | 2 |
container_start_page | 195 |
container_title | Archives of biochemistry and biophysics |
container_volume | 386 |
creator | Maryanoff, Bruce E. Santulli, Rosemary J. McComsey, David F. Hoekstra, William J. Hoey, Kenway Smith, Charles E. Addo, Michael Darrow, Andrew L. Andrade-Gordon, Patricia |
description | Protease-activated receptor-2 (PAR-2) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (−/−) cell line transfected with either human PAR-2 or PAR-1. A “directed” library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-2 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-2. The most potent agonist peptides (EC50 = 2–4 μM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05–0.35 μM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 μM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Ile and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. |
doi_str_mv | 10.1006/abbi.2000.2207 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70851682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003986100922070</els_id><sourcerecordid>70851682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-2416746b23ebf0ba8f1f1e092959d33493eb6affbfb49b48c452c6fafa157c3f3</originalsourceid><addsrcrecordid>eNp1kc1uEzEUhS0EomlhyxLNCrULp_6LM8MuKi1UitSolLXln2swSsaD7YmUl-CZ8ZAIVl1d6dzPn3R9EHpHyZwSIq-1MWHOCCFzxsjyBZpR0klMeCteolmNOe5aSc_Qec4_CaFUSPYanVHKZcsFm6HfmxQL6Ax4ZUvY6wKueQQLQ4kJs-Zys3rE7Opj87Wk0ZYxAb4b-0rGvkajOzTR_-Obk2JamkPzKewhZWg2dRkc5Mpt__pLbJ6g_IAEDq_Dd9275nYIJQ6Q36BXXm8zvD3NC_Tt7vbp5gteP3y-v1mtseWCFMwElUshDeNgPDG69dRTIB3rFp3jXHQ1l9p7443ojGitWDArvfaaLpaWe36BPhy9Q4q_RshF7UK2sN3qHuKY1ZK0CypbVsH5EbQp5pzAqyGFnU4HRYmaGlBTA2pqQE0N1AfvT-bR7MD9x09fXoH2CEC9bx8gqWwD9BZcSGCLcjE85_4DofuWLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70851682</pqid></control><display><type>article</type><title>Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Maryanoff, Bruce E. ; Santulli, Rosemary J. ; McComsey, David F. ; Hoekstra, William J. ; Hoey, Kenway ; Smith, Charles E. ; Addo, Michael ; Darrow, Andrew L. ; Andrade-Gordon, Patricia</creator><creatorcontrib>Maryanoff, Bruce E. ; Santulli, Rosemary J. ; McComsey, David F. ; Hoekstra, William J. ; Hoey, Kenway ; Smith, Charles E. ; Addo, Michael ; Darrow, Andrew L. ; Andrade-Gordon, Patricia</creatorcontrib><description>Protease-activated receptor-2 (PAR-2) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (−/−) cell line transfected with either human PAR-2 or PAR-1. A “directed” library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-2 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-2. The most potent agonist peptides (EC50 = 2–4 μM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05–0.35 μM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 μM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Ile and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists.</description><identifier>ISSN: 0003-9861</identifier><identifier>EISSN: 1096-0384</identifier><identifier>DOI: 10.1006/abbi.2000.2207</identifier><identifier>PMID: 11368342</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>agonist peptides ; Amino Acid Motifs ; Amino Acid Sequence ; Amino Acid Substitution ; Animals ; Blood Platelets - drug effects ; Blood Platelets - metabolism ; Blood Platelets - physiology ; Calcium - metabolism ; Calcium Signaling - drug effects ; Cell Line ; Directed Molecular Evolution ; Dose-Response Relationship, Drug ; Drug Design ; Humans ; intracellular calcium ; Ligands ; Mice ; Peptide Library ; Peptides - chemistry ; Peptides - genetics ; Peptides - metabolism ; Peptides - pharmacology ; Platelet Aggregation - drug effects ; protease-activated receptor ; Rats ; Receptor, PAR-1 ; Receptor, PAR-2 ; Receptors, Thrombin - agonists ; Receptors, Thrombin - chemistry ; Receptors, Thrombin - genetics ; Receptors, Thrombin - metabolism ; structure-activity ; Structure-Activity Relationship ; tethered-ligand receptor ; transfected cells</subject><ispartof>Archives of biochemistry and biophysics, 2001-02, Vol.386 (2), p.195-204</ispartof><rights>2001 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-2416746b23ebf0ba8f1f1e092959d33493eb6affbfb49b48c452c6fafa157c3f3</citedby><cites>FETCH-LOGICAL-c340t-2416746b23ebf0ba8f1f1e092959d33493eb6affbfb49b48c452c6fafa157c3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/abbi.2000.2207$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11368342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maryanoff, Bruce E.</creatorcontrib><creatorcontrib>Santulli, Rosemary J.</creatorcontrib><creatorcontrib>McComsey, David F.</creatorcontrib><creatorcontrib>Hoekstra, William J.</creatorcontrib><creatorcontrib>Hoey, Kenway</creatorcontrib><creatorcontrib>Smith, Charles E.</creatorcontrib><creatorcontrib>Addo, Michael</creatorcontrib><creatorcontrib>Darrow, Andrew L.</creatorcontrib><creatorcontrib>Andrade-Gordon, Patricia</creatorcontrib><title>Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes</title><title>Archives of biochemistry and biophysics</title><addtitle>Arch Biochem Biophys</addtitle><description>Protease-activated receptor-2 (PAR-2) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (−/−) cell line transfected with either human PAR-2 or PAR-1. A “directed” library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-2 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-2. The most potent agonist peptides (EC50 = 2–4 μM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05–0.35 μM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 μM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Ile and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists.</description><subject>agonist peptides</subject><subject>Amino Acid Motifs</subject><subject>Amino Acid Sequence</subject><subject>Amino Acid Substitution</subject><subject>Animals</subject><subject>Blood Platelets - drug effects</subject><subject>Blood Platelets - metabolism</subject><subject>Blood Platelets - physiology</subject><subject>Calcium - metabolism</subject><subject>Calcium Signaling - drug effects</subject><subject>Cell Line</subject><subject>Directed Molecular Evolution</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Design</subject><subject>Humans</subject><subject>intracellular calcium</subject><subject>Ligands</subject><subject>Mice</subject><subject>Peptide Library</subject><subject>Peptides - chemistry</subject><subject>Peptides - genetics</subject><subject>Peptides - metabolism</subject><subject>Peptides - pharmacology</subject><subject>Platelet Aggregation - drug effects</subject><subject>protease-activated receptor</subject><subject>Rats</subject><subject>Receptor, PAR-1</subject><subject>Receptor, PAR-2</subject><subject>Receptors, Thrombin - agonists</subject><subject>Receptors, Thrombin - chemistry</subject><subject>Receptors, Thrombin - genetics</subject><subject>Receptors, Thrombin - metabolism</subject><subject>structure-activity</subject><subject>Structure-Activity Relationship</subject><subject>tethered-ligand receptor</subject><subject>transfected cells</subject><issn>0003-9861</issn><issn>1096-0384</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1uEzEUhS0EomlhyxLNCrULp_6LM8MuKi1UitSolLXln2swSsaD7YmUl-CZ8ZAIVl1d6dzPn3R9EHpHyZwSIq-1MWHOCCFzxsjyBZpR0klMeCteolmNOe5aSc_Qec4_CaFUSPYanVHKZcsFm6HfmxQL6Ax4ZUvY6wKueQQLQ4kJs-Zys3rE7Opj87Wk0ZYxAb4b-0rGvkajOzTR_-Obk2JamkPzKewhZWg2dRkc5Mpt__pLbJ6g_IAEDq_Dd9275nYIJQ6Q36BXXm8zvD3NC_Tt7vbp5gteP3y-v1mtseWCFMwElUshDeNgPDG69dRTIB3rFp3jXHQ1l9p7443ojGitWDArvfaaLpaWe36BPhy9Q4q_RshF7UK2sN3qHuKY1ZK0CypbVsH5EbQp5pzAqyGFnU4HRYmaGlBTA2pqQE0N1AfvT-bR7MD9x09fXoH2CEC9bx8gqWwD9BZcSGCLcjE85_4DofuWLQ</recordid><startdate>20010215</startdate><enddate>20010215</enddate><creator>Maryanoff, Bruce E.</creator><creator>Santulli, Rosemary J.</creator><creator>McComsey, David F.</creator><creator>Hoekstra, William J.</creator><creator>Hoey, Kenway</creator><creator>Smith, Charles E.</creator><creator>Addo, Michael</creator><creator>Darrow, Andrew L.</creator><creator>Andrade-Gordon, Patricia</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010215</creationdate><title>Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes</title><author>Maryanoff, Bruce E. ; Santulli, Rosemary J. ; McComsey, David F. ; Hoekstra, William J. ; Hoey, Kenway ; Smith, Charles E. ; Addo, Michael ; Darrow, Andrew L. ; Andrade-Gordon, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-2416746b23ebf0ba8f1f1e092959d33493eb6affbfb49b48c452c6fafa157c3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>agonist peptides</topic><topic>Amino Acid Motifs</topic><topic>Amino Acid Sequence</topic><topic>Amino Acid Substitution</topic><topic>Animals</topic><topic>Blood Platelets - drug effects</topic><topic>Blood Platelets - metabolism</topic><topic>Blood Platelets - physiology</topic><topic>Calcium - metabolism</topic><topic>Calcium Signaling - drug effects</topic><topic>Cell Line</topic><topic>Directed Molecular Evolution</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Design</topic><topic>Humans</topic><topic>intracellular calcium</topic><topic>Ligands</topic><topic>Mice</topic><topic>Peptide Library</topic><topic>Peptides - chemistry</topic><topic>Peptides - genetics</topic><topic>Peptides - metabolism</topic><topic>Peptides - pharmacology</topic><topic>Platelet Aggregation - drug effects</topic><topic>protease-activated receptor</topic><topic>Rats</topic><topic>Receptor, PAR-1</topic><topic>Receptor, PAR-2</topic><topic>Receptors, Thrombin - agonists</topic><topic>Receptors, Thrombin - chemistry</topic><topic>Receptors, Thrombin - genetics</topic><topic>Receptors, Thrombin - metabolism</topic><topic>structure-activity</topic><topic>Structure-Activity Relationship</topic><topic>tethered-ligand receptor</topic><topic>transfected cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maryanoff, Bruce E.</creatorcontrib><creatorcontrib>Santulli, Rosemary J.</creatorcontrib><creatorcontrib>McComsey, David F.</creatorcontrib><creatorcontrib>Hoekstra, William J.</creatorcontrib><creatorcontrib>Hoey, Kenway</creatorcontrib><creatorcontrib>Smith, Charles E.</creatorcontrib><creatorcontrib>Addo, Michael</creatorcontrib><creatorcontrib>Darrow, Andrew L.</creatorcontrib><creatorcontrib>Andrade-Gordon, Patricia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maryanoff, Bruce E.</au><au>Santulli, Rosemary J.</au><au>McComsey, David F.</au><au>Hoekstra, William J.</au><au>Hoey, Kenway</au><au>Smith, Charles E.</au><au>Addo, Michael</au><au>Darrow, Andrew L.</au><au>Andrade-Gordon, Patricia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes</atitle><jtitle>Archives of biochemistry and biophysics</jtitle><addtitle>Arch Biochem Biophys</addtitle><date>2001-02-15</date><risdate>2001</risdate><volume>386</volume><issue>2</issue><spage>195</spage><epage>204</epage><pages>195-204</pages><issn>0003-9861</issn><eissn>1096-0384</eissn><abstract>Protease-activated receptor-2 (PAR-2) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (−/−) cell line transfected with either human PAR-2 or PAR-1. A “directed” library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-2 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-2. The most potent agonist peptides (EC50 = 2–4 μM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05–0.35 μM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 μM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Ile and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11368342</pmid><doi>10.1006/abbi.2000.2207</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9861 |
ispartof | Archives of biochemistry and biophysics, 2001-02, Vol.386 (2), p.195-204 |
issn | 0003-9861 1096-0384 |
language | eng |
recordid | cdi_proquest_miscellaneous_70851682 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | agonist peptides Amino Acid Motifs Amino Acid Sequence Amino Acid Substitution Animals Blood Platelets - drug effects Blood Platelets - metabolism Blood Platelets - physiology Calcium - metabolism Calcium Signaling - drug effects Cell Line Directed Molecular Evolution Dose-Response Relationship, Drug Drug Design Humans intracellular calcium Ligands Mice Peptide Library Peptides - chemistry Peptides - genetics Peptides - metabolism Peptides - pharmacology Platelet Aggregation - drug effects protease-activated receptor Rats Receptor, PAR-1 Receptor, PAR-2 Receptors, Thrombin - agonists Receptors, Thrombin - chemistry Receptors, Thrombin - genetics Receptors, Thrombin - metabolism structure-activity Structure-Activity Relationship tethered-ligand receptor transfected cells |
title | Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T02%3A09%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protease-Activated%20Receptor-2%20(PAR-2):%20Structure-Function%20Study%20of%20Receptor%20Activation%20by%20Diverse%20Peptides%20Related%20to%20Tethered-Ligand%20Epitopes&rft.jtitle=Archives%20of%20biochemistry%20and%20biophysics&rft.au=Maryanoff,%20Bruce%20E.&rft.date=2001-02-15&rft.volume=386&rft.issue=2&rft.spage=195&rft.epage=204&rft.pages=195-204&rft.issn=0003-9861&rft.eissn=1096-0384&rft_id=info:doi/10.1006/abbi.2000.2207&rft_dat=%3Cproquest_cross%3E70851682%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70851682&rft_id=info:pmid/11368342&rft_els_id=S0003986100922070&rfr_iscdi=true |